Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AKT kinase pathway, also known as the PI3K-AKT or PI3K-Akt signaling pathway, is a central signal transduction cascade that regulates key cellular processes such as metabolism, proliferation, survival, growth, and angiogenesis. It is initiated by extracellular signals via receptor tyrosine kinases or other receptors activating PI3K, leading to PIP3 production and AKT activation. Dysregulation is implicated in many cancers and contributes to insulin resistance/type 2 diabetes. Therapeutic strategies involve targeting various nodes within the pathway with small molecule inhibitors.
Inhibition of AKT kinase activity or upstream regulators to block downstream signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AKT Kinase Pathway (PI3K-AKT).